Taysha Gene Therapies, Inc. (TSHA)

NASDAQ: TSHA · Real-Time Price · USD

3.260

+0.360 (12.41%)

At close: Sep 4, 2025, 4:00 PM

3.259

-0.001 (-0.02%)

After-hours: Sep 4, 2025, 7:55 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Adeno-Associated Viruses-based Gene Therapies	15.45M	Log In
Adeno-Associated Viruses-based Gene Therapies Growth	517.55%	Log In

Revenue by Geography

Fiscal year is January - December.